N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients

Diabetes Research and Clinical Practice

Volumn 69, Issue 3, 2005, Pages 272-278

  Shimada, Satoshi ^a   Tanaka, Yasushi ^a   Ohmura, Chie ^a   Tamura, Yoshifumi ^a   Shimizu, Tomoaki ^a   Uchino, Hiroshi ^a   Watada, Hirotaka ^a   Hirose, Takahisa ^a   Nakaniwa, Tomiko ^a   Miwa, Shinya ^a   Kawamori, Ryuzo ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

AGE; CMV Hb; Diabetes; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN; HYDROGEN PEROXIDE; VALINE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ERYTHROCYTE; EVALUATION; EXTRACTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN PURIFICATION;

DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VALINE;

EID: 23744498113     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.01.007     Document Type: Article

References (24)

1. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, and Y. Kaneda Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage Nature 404 2000 787 790
2. Y.K. Kim, M.S. Lee, S.M. Son, I.J. Kim, W.S. Lee, and B.Y. Rhim Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes Diabetes 51 2002 522 527
3. T. Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonata, and H. Utsumi A possible target of antioxidative therapy for diabetic vascular complications - vascular NAD(P)H oxidase Curr. Med. Chem. 10 2003 1759 1764
4. H. Yan, and J.J. Harding Glycation-induced inactivation and loss of antigenecity of catalase and superoxide dismutase Biochem. J. 328 1997 599 605
5. A. Kashiwagi, T. Asahina, Y. Nishio, M. Ikebuchi, Y. Tanaka, and R. Kikkawa Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells Diabetes 45 1996 S84 S86
6. P. Dandona, K. Thusu, S. Cook, B. Snyder, J. Makowski, and D. Armstrong Oxidative damage to DNA in diabetes mellitus Lancet 347 1996 444 445
7. A. Patrono, and G.A. FitzGerald Isoprostanes: potential markers of oxidant stress in atherothrombotic disease Arterioscler. Thromb. Vasc. Biol. 17 1997 2309 2315
8. E.A. Meagher, O.P. Barry, J.A. Lawson, J. Rokach, and G.A. FitzGerald Effects of Vitamin E on lipid peroxidation in healthy persons JAMA 285 2001 1178 1182
9. ε-carboxymethyllysine as a degeneration product of fructoselysine in glycated protein J. Biol. Chem. 267 1989 3758 3764
10. ε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins Biochemistry 34 1995 10872 10878
11. ε- (carboxymethyl)lysine in healthy controls and diabetic patients Diabetologia 43 2000 1385 1388
12. ε-(carboxymethyl) lysine (CML), is a product of both lipid peroxidation and glycoxidation reactions J. Biol. Chem. 271 1996 9982 9986
13. ε-(carboxymethyl)valine residue in hemoglobin of diabetic patients Diab. Care 24 2001 891 896
14. S. Miwa, M. Inouye, C. Ohmura, N. Mitsuhashi, T. Onuma, and R. Kawamori Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients Diab. Res. Clin. Pract. 61 2003 81 88
15. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
16. J.V. Hunt, R.T. Dean, and S.P. Wolff Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation Biochem. J. 291 1993 529 535
17. K.J. Welis-Knecht, D.V. Xyzak, J.E. Litchfield, S.R. Thorpe, and J.W. Baynes Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose Biochemistry 34 1995 3702 3709
18. D.A. Greene, A.A. Sima, M.J. Stevens, E.L. Feldman, and S.A. Lattimer Complications: neuropathy, pathogenetic considerations Diab. Care 15 1992 1902 1925
19. D. Koya, and G.L. King Protein kinase C activation and the development of diabetic complications Diabetes 47 1998 859 866
20. M. Brownlee Glycation products and the pathogenesis of diabetic complications Diab. Care 15 1992 1835 1843
21. E.D. Schleicher, and C. Weigert Role of the hexosamine biosynthetic pathway in diabetic neuropathy Kidney Int. 77 2000 S13 S18
22. J.W. Baynes, and S.R. Thorpe Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1999 1 9
23. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
24. T. Nomiyama, Y. Tanaka, N. Hattori, K. Nishimaki, K. Nagasaka, and R. Kawamori Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients Diabetologia 45 2002 1577 1583